Heparin-Induced Thrombocytopenia in Neonates

[1]  Anna Saiti,et al.  Decision Making And Problem Solving , 2014 .

[2]  T. Ortel,et al.  Heparin-induced thrombocytopenia. , 2006, Seminars in hematology.

[3]  A. Greinacher,et al.  Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial. , 2003, The Journal of pediatrics.

[4]  D. Silver,et al.  Heparin-induced thrombocytopenia: twenty-nine years later. , 2003, Journal of vascular surgery.

[5]  N. Heddle,et al.  Laboratory diagnosis of immune heparin-induced thrombocytopenia. , 2003, Current hematology reports.

[6]  A. Tortolani,et al.  Diagnosis and treatment of heparin-induced thrombocytopenia , 2003, Perfusion.

[7]  T. Warkentin.  Current agents for the treatment of patients with heparin-induced thrombocytopenia. , 2002, Current opinion in pulmonary medicine.

[8]  J. Bartholomew,et al.  Lepirudin anticoagulation for heparin-induced thrombocytopenia. , 2002, The Journal of pediatrics.

[9]  T. Severin,et al.  Heparin-Induced Thrombocytopenia in Pediatrics , 2001, Seminars in thrombosis and hemostasis.

[10]  J. Kelton,et al.  Temporal aspects of heparin-induced thrombocytopenia. , 2001, The New England journal of medicine.

[11]  J. Bartholomew,et al.  Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia , 2001, Circulation.

[12]  A. Greinacher,et al.  Recombinant Hirudin in Clinical Practice: Focus on Lepirudin , 2001, Circulation.

[13]  AndreasGreinacher,et al.  Recombinant Hirudin in Clinical Practice , 2001 .

[14]  B. Chong,et al.  Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. , 2000, Blood.

[15]  J. Moran,et al.  Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. , 1999, The American journal of medicine.

[16]  R. Barkin,et al.  Newer Strategies for the Treatment of Heparin‐Induced Thrombocytopenia , 1999, Pharmacotherapy.

[17]  Y. Shoenfeld,et al.  High-Dose Intravenous γ-Globulins for Heparin-Induced Thrombocytopenia: A Prompt Response , 1998, Journal of Clinical Immunology.

[18]  J. Kelton,et al.  A 14-year study of heparin-induced thrombocytopenia. , 1996, The American journal of medicine.

[19]  L. Lathan,et al.  Ancrod: the use of snake venom in the treatment of patients with heparin-induced thrombocytopenia and thrombosis undergoing coronary artery bypass grafting: nursing management. , 1996, Heart & lung : the journal of critical care.

[20]  L. Barbour,et al.  Heparin-induced thrombocytopenia and thrombosis: a case study and clinical overview. , 1994, Oncology nursing forum.

[21]  D. Silver,et al.  Heparin-induced thrombocytopenia in the newborn. , 1992, Journal of vascular surgery.

[22]  Lubowski Tj.  Heparin-induced thrombocytopenia and thrombosis. , 1990, Connecticut medicine.

[23]  D. J. King,et al.  Heparin-associated thrombocytopenia. , 1984, Annals of internal medicine.

[24]  D. Morrow.  Heparin and Low–Molecular-Weight Heparin , 2004 .

[25]  L. Risch,et al.  Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. , 2002, Pediatrics.

[26]  E. Ohman,et al.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. , 2001, Chest.

[27]  K. F. Izban,et al.  Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia. , 1999, Seminars in thrombosis and hemostasis.

[28]  Y. Shoenfeld,et al.  High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: a prompt response. , 1998, Journal of clinical immunology.